Population
Patients with or at risk for coronary artery disease
Design
Review
Authors
Loading...
May aid CAD risk stratification; leaves open prospective validation of platelet assays due to current limitations.
Platelet-derived biomarkers offer a conceptually attractive but complex approach for risk stratification in coronary artery disease.
Wang et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: